Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Natuzzi Received Delisting Notice From NYSE

businesswire.com
NTZ

XTI Aerospace, Inc. (XTIA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

globenewswire.com
XTIA

Deadline Alert: Alarum Technologies, Ltd. (ALAR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

globenewswire.com
ALAR

AutoTrust CEO Dave Mondragon: Scale Is Now the Deciding Factor for Dealers

prnewswire.com
HD

Law Offices of Howard G. Smith Encourages Flotek Industries, Inc. (FTK) Shareholders To Inquire About Securities Fraud Class Action

businesswire.com
FTK

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

globenewswire.com
SSP

Opening More Doors to Homeownership in Portland

accessnewswire.com
KEY

Vadzo Imaging Validates Onvif Profile S, T, and G on Innova-234MGS AR0234 2MP Monochrome Gigabit Ethernet Camera for Patient Monitoring Applications

accessnewswire.com
ON

Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

globenewswire.com
ROIV

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

globenewswire.com
ROIV
View all news →